Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Sunday, April 20, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Authors
Posts by admin
admin
1872 POSTS
6 COMMENTS
Regulatory Affairs
Drug Approval Process in India
admin
-
January 4, 2020
0
Clinical Data Management
ECOG Performance Status
admin
-
January 3, 2020
1
Regulatory Affairs
Orphan Drug Designation in US, EU and Japan
admin
-
December 31, 2019
0
Latest Pharma-News
AVITA medical receives U.S. FDA investigational device exemption approval of clinical feasibility study in order to evaluate Recell system for Vitiligo
admin
-
December 30, 2019
0
Regulatory Affairs
The Drug approval process in EU:
admin
-
December 29, 2019
0
Other
Big Change in FDA process for Biologics:
admin
-
December 29, 2019
0
Latest Pharma-News
U.S. Food and Drug Administration (FDA) approved sNDA to Revise Flexion Therapeutic’s ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) for the treatment of osteoarthritis (OA)...
admin
-
December 27, 2019
0
Regulatory Affairs
Biologics Approval Pathways in the USA:
admin
-
December 27, 2019
0
Regulatory Affairs
Generic Products Approval Pathways (USA): Paragraph Certification I, II, III, and IV:
admin
-
December 25, 2019
0
Latest Pharma-News
U.S. Food and Drug Administration (FDA) approved Allergan’s UBRELVY(ubrogepant) for the acute treatment of migraine with or without aura in adults.
admin
-
December 25, 2019
0
Latest Pharma-News
U.S. FDA approves EISAI’S DAYVIGO™ (LEMBOREXANT) for treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adults
admin
-
December 25, 2019
0
Latest Pharma-News
Roche and Sarepta Therapeutics enters licensing agreement in order to improve the lives of patients living with Duchenne muscular dystrophy
admin
-
December 24, 2019
0
1
...
145
146
147
...
156
Page 146 of 156
TOP AUTHORS
admin
1872 POSTS
6 COMMENTS
OIdMIHuOdiu
0 POSTS
0 COMMENTS
tintin
0 POSTS
0 COMMENTS
- Advertisment -
Most Read
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
April 11, 2025
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
April 9, 2025
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
April 9, 2025
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
April 9, 2025